Literature DB >> 24859116

An allosteric switch for pro-HGF/Met signaling using zymogen activator peptides.

Kyle E Landgraf1, Micah Steffek2, Clifford Quan3, Jeffrey Tom3, Christine Yu4, Lydia Santell3, Henry R Maun3, Charles Eigenbrot4, Robert A Lazarus3.   

Abstract

Stimulation of hepatocyte growth factor (HGF) signaling through the Met receptor is an attractive approach for promoting tissue repair and preventing fibrosis. Using structure-guided peptide phage display combined with an activity-based sorting strategy, we engineered allosteric activators of zymogen-like pro-HGF to bypass proteolytic activation and reversibly stimulate pro-HGF signaling through Met. Biochemical, structural and biological data showed that zymogen activator peptides (ZAPtides) potently and selectively bind the activation pocket within the serine protease-like β-chain of pro-HGF and display titratable activation of pro-HGF-dependent Met signaling, leading to cell survival and migration. To further demonstrate the versatility of our ZAPtide platform, we identified allosteric activators for pro-macrophage stimulating protein and a zymogen serine protease, Protein C, which also provides evidence for target selectivity. These studies reveal that ZAPtides use molecular mimicry of the trypsin-like N-terminal insertion mechanism and establish a new paradigm for selective pharmacological activation of plasminogen-related growth factors and zymogen serine proteases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24859116     DOI: 10.1038/nchembio.1533

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


  57 in total

1.  Staphylocoagulase is a prototype for the mechanism of cofactor-induced zymogen activation.

Authors:  Rainer Friedrich; Peter Panizzi; Pablo Fuentes-Prior; Klaus Richter; Ingrid Verhamme; Patricia J Anderson; Shun-Ichiro Kawabata; Robert Huber; Wolfram Bode; Paul E Bock
Journal:  Nature       Date:  2003-10-02       Impact factor: 49.962

2.  Structural basis for agonism and antagonism of hepatocyte growth factor.

Authors:  W David Tolbert; Jennifer Daugherty-Holtrop; Ermanno Gherardi; George Vande Woude; H Eric Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-12       Impact factor: 11.205

3.  Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2.

Authors:  Daniel Kirchhofer; Mark Peek; Michael T Lipari; Karen Billeci; Bin Fan; Paul Moran
Journal:  FEBS Lett       Date:  2005-03-28       Impact factor: 4.124

4.  Unusual proteolytic activation of pro-hepatocyte growth factor by plasma kallikrein and coagulation factor XIa.

Authors:  Mark Peek; Paul Moran; Nerissa Mendoza; Dineli Wickramasinghe; Daniel Kirchhofer
Journal:  J Biol Chem       Date:  2002-10-07       Impact factor: 5.157

Review 5.  Thrombin plasticity.

Authors:  James A Huntington
Journal:  Biochim Biophys Acta       Date:  2011-07-18

6.  Imbalance in the pro-hepatocyte growth factor activation system in bleomycin-induced lung fibrosis in mice.

Authors:  Sophie Phin; Sylvain Marchand-Adam; Aurélie Fabre; Joëlle Marchal-Somme; Claudie Bantsimba-Malanda; Hiroaki Kataoka; Paul Soler; Bruno Crestani
Journal:  Am J Respir Cell Mol Biol       Date:  2009-05-15       Impact factor: 6.914

7.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

8.  Activation of hepatocyte growth factor by proteolytic conversion of a single chain form to a heterodimer.

Authors:  D Naka; T Ishii; Y Yoshiyama; K Miyazawa; H Hara; T Hishida; N Kidamura
Journal:  J Biol Chem       Date:  1992-10-05       Impact factor: 5.157

9.  Diverse and potent activities of HGF/SF in skin wound repair.

Authors:  Damon Bevan; Ermanno Gherardi; Tai-Ping Fan; Dylan Edwards; Richard Warn
Journal:  J Pathol       Date:  2004-07       Impact factor: 7.996

Review 10.  Ron receptor tyrosine kinase signaling as a therapeutic target.

Authors:  Nancy M Benight; Susan E Waltz
Journal:  Expert Opin Ther Targets       Date:  2012-07-26       Impact factor: 6.902

View more
  11 in total

1.  An engineered dimeric fragment of hepatocyte growth factor is a potent c-MET agonist.

Authors:  Cassie J Liu; Douglas S Jones; Ping-Chuan Tsai; Abhishek Venkataramana; Jennifer R Cochran
Journal:  FEBS Lett       Date:  2014-11-21       Impact factor: 4.124

2.  MM-131, a bispecific anti-Met/EpCAM mAb, inhibits HGF-dependent and HGF-independent Met signaling through concurrent binding to EpCAM.

Authors:  Jessica B Casaletto; Melissa L Geddie; Adnan O Abu-Yousif; Kristina Masson; Aaron Fulgham; Antoine Boudot; Tim Maiwald; Jeffrey D Kearns; Neeraj Kohli; Stephen Su; Maja Razlog; Andreas Raue; Ashish Kalra; Maria Håkansson; Derek T Logan; Martin Welin; Shrikanta Chattopadhyay; Brian D Harms; Ulrik B Nielsen; Birgit Schoeberl; Alexey A Lugovskoy; Gavin MacBeath
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-21       Impact factor: 11.205

3.  Macrocyclic peptide-based inhibition and imaging of hepatocyte growth factor.

Authors:  Toby Passioura; Hiroki Sato; Katsuya Sakai; Kenichiro Ito; Hiroki Furuhashi; Masataka Umitsu; Junichi Takagi; Yukinari Kato; Hidefumi Mukai; Shota Warashina; Maki Zouda; Yasuyoshi Watanabe; Seiji Yano; Mikihiro Shibata; Hiroaki Suga; Kunio Matsumoto
Journal:  Nat Chem Biol       Date:  2019-05-17       Impact factor: 15.040

4.  Label-Free, In-Solution Screening of Peptide Libraries for Binding to Protein Targets Using Hydrogen Exchange Mass Spectrometry.

Authors:  Walid S Maaty; David D Weis
Journal:  J Am Chem Soc       Date:  2016-01-21       Impact factor: 15.419

Review 5.  State of the structure address on MET receptor activation by HGF.

Authors:  Edmond M Linossi; Gabriella O Estevam; Masaya Oshima; James S Fraser; Eric A Collisson; Natalia Jura
Journal:  Biochem Soc Trans       Date:  2021-04-30       Impact factor: 5.407

6.  Probing conformational and functional states of human hepatocyte growth factor by a panel of monoclonal antibodies.

Authors:  Masataka Umitsu; Katsuya Sakai; Satoshi Ogasawara; Mika K Kaneko; Ryoko Asaki; Keiko Tamura-Kawakami; Yukinari Kato; Kunio Matsumoto; Junichi Takagi
Journal:  Sci Rep       Date:  2016-09-09       Impact factor: 4.379

7.  Semi-synthesis of a HGF/SF kringle one (K1) domain scaffold generates a potent in vivo MET receptor agonist.

Authors:  Claire Simonneau; Alexandra Mougel; Eric Adriaenssens; Charlotte Paquet; Laurent Raibaut; Nathalie Ollivier; Hervé Drobecq; Julien Marcoux; Sarah Cianférani; David Tulasne; Hugo de Jonge; Oleg Melnyk; Jérôme Vicogne
Journal:  Chem Sci       Date:  2015-01-29       Impact factor: 9.825

8.  Interplay between conformational selection and zymogen activation.

Authors:  Pradipta Chakraborty; Laura Acquasaliente; Leslie A Pelc; Enrico Di Cera
Journal:  Sci Rep       Date:  2018-03-06       Impact factor: 4.379

9.  19F NMR reveals the conformational properties of free thrombin and its zymogen precursor prethrombin-2.

Authors:  Eliza A Ruben; Prafull S Gandhi; Zhiwei Chen; Sarah K Koester; Gregory T DeKoster; Carl Frieden; Enrico Di Cera
Journal:  J Biol Chem       Date:  2020-05-01       Impact factor: 5.157

10.  Role of the I16-D194 ionic interaction in the trypsin fold.

Authors:  Bosko M Stojanovski; Zhiwei Chen; Sarah K Koester; Leslie A Pelc; Enrico Di Cera
Journal:  Sci Rep       Date:  2019-12-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.